Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
284.9 USD | -0.49% | +2.82% | -1.13% |
Mar. 09 | Amgen Presents New Research on Otezla at AAD 2024 | CI |
Mar. 06 | Amgen Keeps Q2 Dividend at $2.25 a Share, Payable June 7 to Stockholders of Record May 17 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.13% | 153B | |
+34.38% | 701B | |
+26.24% | 571B | |
+1.24% | 381B | |
+21.14% | 334B | |
+17.14% | 319B | |
+0.74% | 210B | |
+2.95% | 210B | |
-6.05% | 201B | |
-3.31% | 157B |
- Stock
- Equities
- Stock Amgen Inc. - Nasdaq
- News Amgen Inc.
- Barclays Adjusts Price Target on Amgen to $228 From $230, Maintains Equal-Weight Rating